This continuous survey (The Clinical Trials Implementation Monitor, or “CTiMonitor”) aims to build knowledge on how the implementation of the Clinical Trials Regulation (CTR), (EU) No. 536/2014 is progressing in different European Countries. This information is of interest to various stakeholders including Pharmaceutical Industry Regulators, the Commission and national Ministries. The first survey was sent to the EFPIA National Trade Associations (NTAs) Regulatory Network, and covered the 4Q/2014 period. This, the second survey, covers the 1Q/2015 period. The survey will be repeated quarterly until mid-2016.